William C. Dougall

Amgen (United States) — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

53h-index14.3kcitations160works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bone Metabolism and Diseases(66), Bone health and treatments(51), Cytokine Signaling Pathways and Interactions(46), NF-κB Signaling Pathways(27), Cancer Immunotherapy and Biomarkers(22)

Publications160 total

Correlation of RANK and RANKL with mammographic density in primary breast cancer patients
Archives of Gynecology and Obstetrics·2024Open Access
RANK and RANKL Expression in Tumors of Patients with Early Breast Cancer
TumorDiagnostik & Therapie·2024Open Access
Author Correction: The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation
Nature Immunology·2024· 1 citedOpen Access
RANK and RANKL Expression in Tumors of Patients with Early Breast Cancer
Geburtshilfe und Frauenheilkunde·2023· 6 citedOpen Access
NMDAR antagonists suppress tumor progression by regulating tumor-associated macrophages
Proceedings of the National Academy of Sciences·2023· 24 citedOpen Access
Supplementary Methods and Legends from CD96 Is an Immune Checkpoint That Regulates CD8<sup>+</sup> T-cell Antitumor Function
2023Open Access
Supplementary Data from CD96 Is an Immune Checkpoint That Regulates CD8<sup>+</sup> T-cell Antitumor Function
2023Open Access
Supplementary Methods and Legends from CD96 Is an Immune Checkpoint That Regulates CD8<sup>+</sup> T-cell Antitumor Function
2023Open Access
Data from CD96 Is an Immune Checkpoint That Regulates CD8<sup>+</sup> T-cell Antitumor Function
2023Open Access
Supplementary Data from CD96 Is an Immune Checkpoint That Regulates CD8<sup>+</sup> T-cell Antitumor Function
2023Open Access
Data from CD96 Is an Immune Checkpoint That Regulates CD8<sup>+</sup> T-cell Antitumor Function
2023Open Access
Supplementary Figure 6 from RANK Induces Epithelial–Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis
2023Open Access
Supplementary Figure 7 from RANK Induces Epithelial–Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis
2023Open Access
Supplementary Figure 2 from RANK Induces Epithelial–Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis
2023Open Access
Supplementary Table S1 from RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation
2023Open Access
Supplementary Figure 6 from RANK Induces Epithelial–Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis
2023Open Access
Supplementary Figure 5 from RANK Induces Epithelial–Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis
2023Open Access
Supplementary Figure 2 from RANK Induces Epithelial–Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis
2023Open Access
Supplementary Figure S4 from RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation
2023Open Access
Supplementary Figure 7 from RANK Induces Epithelial–Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Mark J. Smyth(12), Michele W.L. Teng(9), Allison Armstrong(7), Mark Tometsko(6), Elizabeth Ahern(6), Eva González‐Suárez(5), Daniel Branstetter(5), Xiaolan Qian(5), David Cosman(4), Kimberley Stannard(4), Kyohei Nakamura(4), Tobias Bald(4), Ailin Lepletier(4), Dirk Anderson(3), Paul J. Kostenuik(3), Jon C. Jones(3), Robert E. Miller(3), Harry S. Nick(3), Heidi Harjunpää(3), Indrajit Das(3)